期刊
INTERNATIONAL JOURNAL OF CANCER
卷 123, 期 11, 页码 2636-2643出版社
WILEY
DOI: 10.1002/ijc.23838
关键词
prostate cancer; Her-2/neu; DNA index; progression; metastasis; PCa-specific death; prognosis
类别
资金
- The Johns Hopkins University Prostate Cancer SPORE [P50CA58230]
- Early Detection Research Network (EDRN) NCI/NIH [CA08623-06]
- Prostate Cancer Foundation. Patana Funda
Abnormal DNA content in tumor cells represents large scale chromosomal alterations and reflects later changes of genetic instbility. Her-2/neu oncogene is amplified in 20-30% of breast and ovarian cancer patients and is associated with poor prognosis. Therefore, we evaluated prognostic value of Her-2/neu expression and DNA content measurements in 252 clinically localized PCa patients with long-term follow-tip after radical prostatectomy for progression, metastasis and PCa-specific death. Her-2/neu expression was determined by immunohistochemistry 'v and DNA content measurements employed Feulgen-stained cancer nuclei captured using static image cytometry system. Cox proportional hazard regression and Kaplan-Meir plots were used to identify significant prognostic factors for progression, metastasis and PCa-specific death. The proportions of Her-2/neu positive and high %DNA index tumors significantly increased from nonprogressor to progressors without metastasis to progressors with metastasis (17 < 0.0001, <0.0001). Further, the proportions of Her-2/neu positive and high %DNA index, tumors significantly increased from patients who died from another cause without progression to those who (lied from another cause with progression to those (lied with PCa-specific death (p = 0.027, <0.0001). Her-2/neu expression and %DNA index were significant prognosticators for progression (P <= 0.001), metastasis (p <= 0.01) PCa-specific death (p <= 0.04) univariate analyses. Multivariately, Her-2/neu expression and %DNA index were also significant for progression (p = 0.001). metastasis (p = 0.001) and PCa-specific death (p = 0.02). When all P other clinicopathologic information is available, the increment in concordance index by addition of either Her-2/neu or DNA index was similar to 2% and of both biomarkers was similar to 3% for progression, metastasis and PCa-specific death free survival models. Therefore, patients with Her-2/neu positive and high %DNA index are at a higher risk for disease progression, metastasis and PCa-specific death. Further, Her-2/neu expression and %DNA index may be used with clinicopathologic parameters for prediction of long-term prognosis in PCa.(C) 2008 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据